The promise of the Information Age has materialized dramatically in many sectors—most notably, commerce and entertainment. But for some fields, the progress has been slower.
Life sciences is perhaps a prime example. Mark Fischer-Colbrie describes life sciences as an “…1850 artisan-style of operation that needs to be brought up to today’s standards.” That’s why he joined Strateos as the CEO in 2019.
In this edition of Uptech Report, Mark discusses how Strateos is turning life science into information science with what they call the “cloud lab.” It’s an information workflow system that could enable scientific advancements to come faster, cheaper, and more often.
More information: https://www.strateos.com/
Mark Fischer-Colbrie became CEO of Strateos in May 2019 following the successful sale of Labcyte Inc., a global laboratory tools company, to Danaher. He has more than 30 years of experience in building and growing laboratory tools, diagnostic, medical device and therapeutic companies, including 3 Initial Public Offerings. In 2013, Mark was named National Finalist, Life Sciences for the Ernst & Young National Entrepreneur of the Year and Entrepreneur of the Year, Life Sciences for Northern California.
Prior to Strateos, Mark was CEO for over ten years at Labcyte Inc. which invented novel lab tools and automation based on acoustic dispensing. Before Labcyte, Mark ran business development and was CFO at Adeza Biomedical Corporation, a women’s healthcare company, where he filed 9 patent applications and set up and ran clinical trials for diagnostics.
Mark has served as Chairman of JDRF’s International Board of Directors, the largest global funder of type one diabetes research, and served on the JDRF IBOD for seven years. Mark has also served on the industry board of the Analytical, Life Sciences Diagnostics Association (ALDA) since 2011. Mark enjoys participating in long distance triathlon and running events.